
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-10-29 10:10:55Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 29 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read More
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-10-01 10:10:27Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 July 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Vista Pharmaceuticals Ltd Falls to 52-Week Low of Rs 5.5 as Sell-Off Deepens
2026-09-08 14:45:14For the second consecutive session, Vista Pharmaceuticals Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 5.5 on 8 Sep 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 5.41% loss over just two days, underscoring persistent selling pressure amid broader market weakness.
Read More
Vista Pharmaceuticals Ltd is Rated Strong Sell
2026-08-27 10:10:22Vista Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 July 2024. However, the analysis and financial metrics discussed below reflect the company’s current position as of 27 August 2026, providing investors with the latest insights into the stock’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
12-Sep-2026 | Source : BSEResignation of Company Secretary & Compliance Officer
Board Meeting Outcome for Results For The Quarter Ended 30.06.2026
14-Aug-2026 | Source : BSEResults for the quarter ended 30.06.2026
Results For The Quarter Ended 30.06.2026
14-Aug-2026 | Source : BSEResults for the quarter ended 30.06.2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available